Tag Archives: Acute

Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »

Low Tidal Volume Ventilation Trial in Acute Respiratory Failure Not Feasible

December 17, 2018 Share this content: The trial would need to enroll approximately 107,373 patients to have a 96% power to detect a 3% improvement in mortality at 80% to 100% adherence to low tidal volume ventilation. A cluster-randomized clinical trial of low tidal volume ventilation vs usual care in patients with acute respiratory failure… Read More »

Which Drug Combination Works Best to Reduce Acute COPD Exacerbations?

November 20, 2018 Share this content: A higher blood eosinophil count was associated with a greater protective effect of ICS/LABA/LAMA against severe acute COPD exacerbations. A combination of inhaled corticosteroids (ICS)/long-acting β2-agonist (LABA)/long-acting muscarinic receptor antagonist (LAMA) is possibly more effective than a LABA/LAMA combination or single long-acting bronchodilator therapy in reducing the risk for… Read More »

Acute bronchitis symptoms appear 3-4 days after a cold

Acute bronchitis is often caused by the virus. It appears frequently in cold periods, usually after an episode of respiratory virus (flu) or influenza viruses produced by one of: coronavirus, adenovirus and rhinovirus. Respiratory syncytial virus can cause acute bronchitis especially in elderly people (over 65 years). In 10% of cases, acute bronchitis is caused… Read More »